Lemonade Inc (LMND) concluded trading on Thursday at a closing price of $23.77, with 9.62 million shares of worth about $228.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 33.99% during that period and on October 31, 2024 the price saw a gain of about 26.77%. Currently the company’s common shares owned by public are about 70.16M shares, out of which, 51.38M shares are available for trading.
Stock saw a price change of 25.44% in past 5 days and over the past one month there was a price change of 45.65%. Year-to-date (YTD), LMND shares are showing a performance of 47.37% which increased to 117.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.64 but also hit the highest price of $24.55 during that period. The average intraday trading volume for Lemonade Inc shares is 1.30 million. The stock is currently trading 30.52% above its 20-day simple moving average (SMA20), while that difference is up 32.26% for SMA50 and it goes to 36.66% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lemonade Inc (NYSE: LMND) currently have 70.16M outstanding shares and institutions hold larger chunk of about 42.28% of that.
The stock has a current market capitalization of $1.69B and its 3Y-monthly beta is at 1.77. It has posted earnings per share of -$2.97 in the same period. It has a debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LMND, volatility over the week remained 8.36% while standing at 5.44% over the month.
Stock’s fiscal year EPS is expected to rise by 11.69% while it is estimated to increase by 16.06% in next year. EPS is likely to grow at an annualized rate of 19.50% for next 5-years, compared to annual growth of -29.47% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by TD Cowen on January 10, 2024 offering a Market perform rating for the stock and assigned a target price of $17 to it. On June 20, 2023, Morgan Stanley Initiated their recommendations, while on January 20, 2023, BMO Capital Markets Initiated their ratings for the stock with a price target of $10. Stock get a Mkt perform rating from Keefe Bruyette on November 17, 2022.
